Both hydrogen peroxide and transforming growth factor beta 1 contribute to endothelial Nox4 mediated angiogenesis in endothelial Nox4 transgenic mouse lines

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 12, 2014, Pages 2489-2499

  Chen, Lili ^a,b   Hou, Xiuyun ^a   Xiao, Jennifer ^a   Kuroda, Junya ^c,d   Ago, Tetsuro ^c,d   Sadoshima, Junichi ^c   Cohen, Richard A ^a   Tong, XiaoYong ^e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tongji Hospital   (China)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d KYUSHU UNIVERSITY   (Japan)

^e CHONGQING UNIVERSITY   (China)

Author keywords

Angiogenesis; Cell signaling; Endothelium; Nox4; Transforming growth factor beta 1

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN RECEPTOR 2; NOX4 PROTEIN, HUMAN; OXIDIZING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; LIMB ISCHEMIA; MOLECULAR WEIGHT; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WILD TYPE; ANIMAL; CELL CULTURE; CELL HYPOXIA; CELL MOTION; DRUG EFFECTS; GENETICS; HINDLIMB; ISCHEMIA; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; VASCULARIZATION;

MUS; MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HINDLIMB; HUMANS; HYDROGEN PEROXIDE; ISCHEMIA; MICE, TRANSGENIC; NADPH OXIDASE; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDANTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84918492138     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.10.007     Document Type: Article

References (32)

1. Stocker R., Keaney J.F. New insights on oxidative stress in the artery wall. J. Thromb. Haemost. 2005, 3:1825-1834.
2. Tong X., Hou X., Jourd'heuil D., Weisbrod R.M., Cohen R.A. Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. Circ. Res. 2010, 107:975-983.
3. Tong X., Ying J., Pimentel D.R., Trucillo M., Adachi T., Cohen R.A. High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration. J. Mol. Cell. Cardiol. 2008, 44:361-369.
4. Tong X., Schröder K. NADPH oxidases are responsible for the failure of nitric oxide to inhibit migration of smooth muscle cells exposed to high glucose. Free Radic. Biol. Med. 2009, 47:1578-1583.
5. Judkins C.P., Diep H., Broughton B.R.S., Mast A.E., Hooker E.U., Miller A.A., Selemidis S., Dusting G.J., Sobey C.G., Drummond G.R. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H24-H32.
6. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., Wakisaka M., Ibayashi S., Utsumi H., Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004, 109:227-233.
7. Craige S.M., Chen K., Pei Y., Li C., Huang X., Chen C., Shibata R., Sato K., Walsh K., Keaney J.F. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 2011, 124:731-740.
8. Zhang M., Brewer A.C., Schröder K., Santos C.X.C., Grieve D.J., Wang M., Anilkumar N., Yu B., Dong X., Walker S.J., Brandes R.P., Shah A.M. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18121-18126.
9. Schroder K., Zhang M., Benkhoff S., Mieth A., Pliquett R., Kosowski J., Kruse C., Luedike P., Michaelis U.R., Weissmann N., Dimmeler S., Shah A.M., Brandes R.P. Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase. Circ. Res. 2012, 110:1217-1225.
10. Ray R., Murdoch C.E., Wang M., Santos C.X., Zhang M., Alom-Ruiz S., Anilkumar N., Ouattara A., Cave A.C., Walker S.J., Grieve D.J., Charles R.L., Eaton P., Brewer A.C., Shah A.M. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1368-1376.
11. Touyz R.M., Montezano A.C. Vascular Nox4: a multifarious NADPH oxidase. Circ. Res. 2012, 110:1159-1161.
12. Ago T., Kuroda J., Kamouchi M., Sadoshima J., Kitazono T. Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. -Review and perspective-. Circ. J. 2011, 75:1791-1800.
13. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M.D., Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15565-15570.
14. Evangelista A.M., Thompson M.D., Bolotina V.M., Tong X., Cohen R.A. Nox4- and Nox2-dependent oxidant production is required for VEGF-induced SERCA cysteine-674 S-glutathiolation and endothelial cell migration. Free Radic. Biol. Med. 2012, 53(12):2327-2334.
15. Evangelista A.M., Thompson M.D., Weisbrod R.M., Pimental D.R., Tong X., Bolotina V.M., Cohen R.A. Redox Regulation of SERCA2 Is Required for Vascular Endothelial Growth Factor-Induced Signaling and Endothelial Cell Migration. Antioxid. Redox Signal. 2012, 17:1099-1108.
16. Mahabeleshwar G.H., Somanath P.R., Byzova T.V. Methods for isolation of endothelial and smooth muscle cells and in vitro proliferation assays. Methods Mol. Med. 2006, 129:197-208.
17. Chen K., Kirber M.T., Xiao H., Yang Y., Keaney J.F. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 2008, 181:1129-1139.
18. Nagata D., Mogi M., Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J. Biol. Chem. 2003, 278:31000-31006.
19. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
20. Peshavariya H.M., Chan E.C., Liu G.S., Jiang F., Dusting G.J. Transforming growth factor-β1 requires NADPH oxidase 4 for angiogenesis in vitro and in vivo. J. Cell. Mol. Med. 2014, 18:1172-1183.
21. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karlsson S., Akhurst R.J. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Dev. (Camb.) 1995, 121:1845-1854.
22. Oh S.P., Seki T., Goss K.a, Imamura T., Yi Y., Donahoe P.K., Li L., Miyazono K., ten Dijke P., Kim S., Li E. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2626-2631.
23. Oshima M., Oshima H., Taketo M.M. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 1996, 179:297-302.
24. Azhar M., Schultz J.E.J., Grupp I., Dorn G.W., Meneton P., Molin D.G.M., Gittenberger-de Groot A.C., Doetschman T. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev. 2003, 14:391-407.
25. Pepper M.S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 1997, 8:21-43.
26. Darland D.C., D'Amore P.A. TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 2001, 4:11-20.
27. Ma J., Wang Q., Fei T., Han J.-D.J., Chen Y.-G. MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration. Blood 2007, 109:987-994.
28. Inoue N., Venema R.C., Sayegh H.S., Ohara Y., Murphy T.J., Harrison D.G. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler. Thromb. Vasc. Biol. 1995, 15:1255-1261.
29. Saura M., Zaragoza C., Cao W., Bao C., Rodríguez-Puyol M., Rodríguez-Puyol D., Lowenstein C.J. Smad2 mediates transforming growth factor-beta induction of endothelial nitric oxide synthase expression. Circ. Res. 2002, 91:806-813.
30. Khalil N. TGF-beta: from latent to active. Microbes Infect. Inst. Pasteur 1999, 1:1255-1263.
31. Liu C., Liang B., Wang Q., Wu J., Zou M.-H. Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin. J. biol. chem. 2010, 285:15346-15355.
32. De Palma M., Venneri M.A., Galli R., Sergi L.S., Politi L.S., Sampaolesi M., Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8:211-226.